NCT05164666View on ClinicalTrials.gov

A Study of TAK-103 in Adult With Solid Tumors

PHASE1TerminatedINTERVENTIONAL
Enrollment

2

Participants

Timeline

Start Date

January 5, 2022

Primary Completion Date

February 22, 2025

Study Completion Date

February 22, 2025

Conditions
Solid Tumors
Interventions
BIOLOGICAL

TAK-103

TAK-103 intravenous infusion

Trial Locations (3)

Unknown

National Cancer Center Hospital East, Kashiwa

Hyogo College of Medicine Hospital, Nishinomiya

National Cancer Center Hospital, Chuo-ku

Sponsors

Lead Sponsor

Takeda
All Listed Sponsors
lead

Takeda

INDUSTRY